The phase II study of recurrent glioblastoma in Japan has published in “Neuro-Oncology Advances”

The title is “Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study”. It is a phase II study in Japan commissioned by Stella Pharma and Sumitomo Heavy Industries. It is a compilation of the contents of the poster presentation at SNO (Society for Neuro Oncology) in 2020.